What is the current Coronary Heart Disease Occluder market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Coronary Heart Disease Occluder market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Coronary Heart Disease Occluder market?

Increasing prevalence of coronary heart disease and technological advancements drive the market.

What are the major challenges facing the Coronary Heart Disease Occluder market?

High costs and limited reimbursement options pose significant challenges.

Which regions are expected to lead the Coronary Heart Disease Occluder market?

North America and Europe are anticipated to dominate the market.

Who are the top companies in the Coronary Heart Disease Occluder market?

Major players include Medtronic, Abbott, and Boston Scientific.

What future opportunities exist in the Coronary Heart Disease Occluder market?

Emerging markets and innovative technologies offer significant future outlook.

How will technology impact the Coronary Heart Disease Occluder market?

Advances in material science and minimally invasive procedures will drive growth.

What is the current regulatory landscape for the Coronary Heart Disease Occluder market?

Stringent regulations and safety standards govern the market.

What is the future outlook for the Coronary Heart Disease Occluder market size?

The market is expected to reach USD 2.5 billion by 2033.

Coronary Heart Disease Occluder Growth Drivers & Forecast Analysis 2033

Coronary Heart Disease Occluder by Application (Hospitals, Clinics), by Types (ASD Occluder, VSD Occluder, PDA Occluder), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $261 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $261 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Coronary Heart Disease Occluder Market Overview

The Coronary Heart Disease Occluder market refers to the industry that develops and manufactures devices used to treat coronary heart disease, a condition where the coronary arteries become narrowed or blocked. The Coronary Heart Disease Occluder market size was estimated to be around $1.3 billion in 2025. As the Coronary Heart Disease Occluder market continues to grow, it is expected to witness a significant growth outlook, with a market forecast indicating a compound annual growth rate (CAGR) of 7.5% during the forecast period from 2026 to 2033. This industry expansion can be attributed to various factors, including advancements in medical technology, increasing prevalence of coronary heart disease, and rising demand for minimally invasive procedures. The scope of this market encompasses various types of occluders, including septal occluders and vascular occluders, which are used to treat different types of coronary heart disease.

Loading chart…

The growth of the Coronary Heart Disease Occluder market is driven by several key forces, including technology shifts, such as the development of more advanced and minimally invasive occluders, regulations, such as the increasing scrutiny of medical device safety and efficacy, and consumer behavior, such as the growing demand for more effective and convenient treatment options. The largest region for the Coronary Heart Disease Occluder market is currently North America, while the fastest-growing region is expected to be the Asia-Pacific region, driven by increasing healthcare expenditure and a growing prevalence of coronary heart disease. Overall, the Coronary Heart Disease Occluder market is expected to continue to grow and evolve in the coming years, driven by advancements in technology, changing regulatory landscapes, and shifting consumer preferences.

Report Overview

Report Attribute	Details
Market size value in 2025	261.00 million
Revenue forecast in 2033	455.20 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; Boston Scientific; LifeTech; Lepu Medical; Occlutech; W. L. Gore & Associates; Starway; Coherex Medical; Cardia; MicroPort
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Increasing prevalence of coronary heart disease is driving the demand for Coronary Heart Disease Occluder market, with the global incidence expected to rise due to factors such as aging population and lifestyle changes

Advancements in medical technology, including the development of minimally invasive procedures and innovative occluder designs, are contributing to the growth forecast of the Coronary Heart Disease Occluder market size

Restraints2 items

High costs associated with coronary heart disease occluder procedures and devices are limiting the adoption rates, particularly in developing economies with limited healthcare budgets and reimbursement options

Stringent regulatory requirements and rigorous testing protocols for new occluder devices are slowing the pace of innovation and constraining the Coronary Heart Disease Occluder market growth

Opportunities2 items

Emerging markets in Asia-Pacific and Latin America present significant opportunities for Coronary Heart Disease Occluder market expansion, driven by growing healthcare infrastructure and increasing patient awareness

Developing novel, cost-effective occluder designs and materials can help manufacturers tap into the vast, underserved patient population and boost the overall Coronary Heart Disease Occluder market size

Challenges2 items

Intensifying competition among established players and new entrants in the Coronary Heart Disease Occluder market is leading to pricing pressures and forcing manufacturers to invest heavily in research and development

Managing supply chain disruptions and maintaining product quality while adhering to regulatory standards are critical challenges that manufacturers must overcome to ensure a stable growth forecast for the Coronary Heart Disease Occluder market

Market Segmentation

Loading chart…

The Coronary Heart Disease Occluder segmentation by application refers to the different uses of occluders in treating coronary heart disease. This market is driven by the increasing prevalence of coronary heart disease and the growing demand for minimally invasive procedures. The application segment contributes to the overall market size by providing a range of treatment options for patients with coronary heart disease, including atrial septal defect and patent ductus arteriosus closures.

The types of Coronary Heart Disease Occluders include different subtypes, such as [object Object] and [object Object], which cater to various patient needs. The types segment is a crucial component of the overall market, as it offers a variety of product options for healthcare providers to choose from, ultimately driving the growth of the market taxonomy. This segment is expected to witness significant growth due to advancements in technology and the increasing adoption of occluders in coronary heart disease treatment.

Coronary Heart Disease Occluder Segmentation Breakdown7 items

Application

Hospitals

Clinics

Types

ASD Occluder

VSD Occluder

PDA Occluder

Regional Insights

Loading chart…

The Coronary Heart Disease Occluder market growth is anticipated to vary across regions, with the largest share held by North America, accounting for approximately 35% of the global market. The fastest-growing region is expected to be Asia Pacific, driven by increasing adoption of advanced medical technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics awareness, and established infrastructure. In Europe, drivers include a strong regulatory framework, increasing adoption of minimally invasive procedures, and a growing geriatric population. Asia Pacific's growth is fueled by rising healthcare expenditure, expanding medical tourism, and growing demand for advanced cardiac treatments.

Latin America and Middle East & Africa are expected to witness moderate growth, driven by improving infrastructure, increasing awareness about coronary heart disease, and growing demand for effective treatments. Factors such as regional forecast, market trends, and competitive landscape will influence the Coronary Heart Disease Occluder market growth in these regions.

Competitive Landscape

The Coronary Heart Disease Occluder market exhibits a moderately consolidated structure, driven by a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The Coronary Heart Disease Occluder competitive landscape is characterized by high competition, with companies focusing on differentiators such as technology, service model, and channel strength to gain market share.

Companies in this market employ various strategies, including M&A, partnerships, product launches, expansion, R&D, and localization, to stay competitive. However, they face challenges such as margin pressure, compliance costs, and commoditization. To differentiate themselves, companies focus on technology, service model, channel strength, customization, and cost advantages. The following companies have notable strategic focuses:

Abbott: regional expansion

Boston Scientific: innovation pipeline

LifeTech: local manufacturing

Lepu Medical: OEM tie-ups

Occlutech: premium pricing

W. L. Gore & Associates: vertical integration

Key Coronary Heart Disease Occluder Companies10 items

Abbott

Boston Scientific

LifeTech

Lepu Medical

Occlutech

W. L. Gore & Associates

Starway

Coherex Medical

Cardia

MicroPort

Market Ecosystem

The Coronary Heart Disease Occluder ecosystem encompasses a complex network of stakeholders, spanning upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three stages: upstream, where raw materials and components are sourced; midstream, where devices are manufactured and integrated; and downstream, where products are distributed and used by end users. The value chain analysis of this ecosystem reveals how value is created and captured at each stage, from research and development to patient care.

Raw material/component suppliers — provide critical materials

OEMs / manufacturers — design and produce occluders

Technology providers — develop underlying technologies

System integrators / EPCs — integrate devices into healthcare systems

Distributors / channel partners — deliver products to healthcare providers

Service providers / after-sales — offer maintenance and support services

Regulators/standards bodies — establish and enforce industry standards

The flow of value within the Coronary Heart Disease Occluder ecosystem is influenced by various control points, including regulatory approvals and reimbursement policies. Dependency risks, such as input constraints and standards compliance, can impact the availability and adoption of occluders. Furthermore, switching costs, partnerships, and interoperability requirements can affect the flexibility and resilience of the ecosystem. As the ecosystem differs by region, due to variations in healthcare infrastructure and regulatory frameworks, understanding these regional nuances is crucial for navigating the global Coronary Heart Disease Occluder ecosystem.

Recent Industry Insights

The Coronary Heart Disease Occluder industry has witnessed significant developments over the last 12-18 months, shaping the future of Coronary Heart Disease Occluder industry trends. Recent partnerships, such as collaborations between medical device manufacturers and research institutions, have accelerated innovation in the field. Furthermore, mergers and acquisitions have led to the expansion of product portfolios and the strengthening of market positions. Notable product launches have also introduced advanced technologies, enhancing treatment outcomes for patients with coronary heart disease.

Additionally, regulatory changes have influenced the growth of the Coronary Heart Disease Occluder market, with a greater emphasis on safety and efficacy. A shift in consumer trends towards minimally invasive procedures has also driven the demand for occluder devices. Moreover, funding rounds and expansions have enabled companies to invest in research and development, driving the Coronary Heart Disease Occluder industry trends forward.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Coronary Heart Disease Occluder market outlook. The market attractiveness is moderate, driven by an increasing prevalence of coronary heart disease and advancements in occluder technology. The competitive intensity is high, with several key players competing for market share. The long-term outlook is positive, with growing demand for minimally invasive procedures and ongoing innovation in the field. The innovation landscape is characterized by the development of new materials and designs, which is expected to drive growth. However, the demand-supply balance is a key risk factor, as supply chain disruptions and regulatory challenges may impact market growth.

12 items

1. Executive Summary

2. Coronary Heart Disease Occluder Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Coronary Heart Disease Occluder Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Coronary Heart Disease Occluder Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Coronary Heart Disease Occluder Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Coronary Heart Disease Occluder Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Coronary Heart Disease Occluder Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Coronary Heart Disease Occluder Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Coronary Heart Disease Occluder Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Coronary Heart Disease Occluder Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Coronary Heart Disease Occluder Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Coronary Heart Disease Occluder Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Coronary Heart Disease Occluder Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Coronary Heart Disease Occluder Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Coronary Heart Disease Occluder Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Coronary Heart Disease Occluder Market Competition by Key Manufacturers

9.1. Global Coronary Heart Disease Occluder Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Coronary Heart Disease Occluder: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Abbott

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Boston Scientific

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. LifeTech

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Lepu Medical

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Occlutech

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. W. L. Gore & Associates

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Starway

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Coherex Medical

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Cardia

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. MicroPort

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Coronary Heart Disease Occluder Market

Figure 4: Global Coronary Heart Disease Occluder Market: Drivers

Figure 5: Global Coronary Heart Disease Occluder Market: Challenges

Figure 6: Global Coronary Heart Disease Occluder Market: Trends

Figure 7: Global Coronary Heart Disease Occluder Market: Opportunity

Figure 8: Global Coronary Heart Disease Occluder Market: Restraint

Figure 9: Global Coronary Heart Disease Occluder Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Coronary Heart Disease Occluder Market Value (USD Million) By Region

Figure 19: Global Coronary Heart Disease Occluder Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Coronary Heart Disease Occluder Market Value (USD Million) By Region

Figure 27: Global Coronary Heart Disease Occluder Market Share (%) By: Regions (2032)

Figure 28: Global Coronary Heart Disease Occluder Market Volume (K) By Region

Figure 29: Global Coronary Heart Disease Occluder Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Coronary Heart Disease Occluder Market Value (USD Million) By Region

Figure 37: Global Coronary Heart Disease Occluder Market Share (%) By: Regions (2032)

Figure 38: Global Coronary Heart Disease Occluder Market Volume (K) By Region

Figure 39: Global Coronary Heart Disease Occluder Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global Coronary Heart Disease Occluder Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Coronary Heart Disease Occluder Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Coronary Heart Disease Occluder Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Coronary Heart Disease Occluder Market Value (USD Million) By Region

Table 14: Global Coronary Heart Disease Occluder Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Coronary Heart Disease Occluder Market Volume (K) By Region

Table 31: Global Coronary Heart Disease Occluder Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Coronary Heart Disease Occluder Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Coronary Heart Disease Occluder Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Coronary Heart Disease Occluder Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Abbott Basic Information And Sales Area

Table 52: Abbott. Products Portfolio

Table 53: Boston Scientific Basic Information And Sales Area

Table 54: Boston Scientific. Products Portfolio

Table 55: LifeTech Basic Information And Sales Area

Table 56: LifeTech. Products Portfolio

Table 57: Lepu Medical Basic Information And Sales Area

Table 58: Lepu Medical. Products Portfolio

Table 59: Occlutech Basic Information And Sales Area

Table 60: Occlutech. Products Portfolio

Table 61: W. L. Gore & Associates Basic Information And Sales Area

Table 62: W. L. Gore & Associates. Products Portfolio

Table 63: Starway Basic Information And Sales Area

Table 64: Starway. Products Portfolio

Table 65: Coherex Medical Basic Information And Sales Area

Table 66: Coherex Medical. Products Portfolio

Table 67: Cardia Basic Information And Sales Area

Table 68: Cardia. Products Portfolio

Table 69: MicroPort Basic Information And Sales Area

Table 70: MicroPort. Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Coronary Heart Disease Occluder Market Value (USD Million) By Region

Table 80: Global Coronary Heart Disease Occluder Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Application

Table 83: North America Market Value (USD Million) (2025-2032) By Types

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Types

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Types

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 96: Global Coronary Heart Disease Occluder Market Volume (K) By Region

Table 97: Global Coronary Heart Disease Occluder Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Application

Table 100: North America Market Volume (K) (2025-2032) By Types

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Types

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Types

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Coronary Heart Disease Occluder Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	261.00 million
Revenue forecast in 2033	455.20 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; Boston Scientific; LifeTech; Lepu Medical; Occlutech; W. L. Gore & Associates; Starway; Coherex Medical; Cardia; MicroPort
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Stringent regulatory requirements and rigorous testing protocols for new occluder devices are slowing the pace of innovation and constraining the Coronary Heart Disease Occluder market growth

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Coronary Heart Disease Occluder Segmentation Breakdown7 items

Application

Hospitals

Clinics

Types

ASD Occluder

VSD Occluder

PDA Occluder

Regional Insights

Loading chart…

Competitive Landscape

Abbott: regional expansion

Boston Scientific: innovation pipeline

LifeTech: local manufacturing

Lepu Medical: OEM tie-ups

Occlutech: premium pricing

W. L. Gore & Associates: vertical integration

Key Coronary Heart Disease Occluder Companies10 items

Abbott

Boston Scientific

LifeTech

Lepu Medical

Occlutech

W. L. Gore & Associates

Starway

Coherex Medical

Cardia

MicroPort

Market Ecosystem

Raw material/component suppliers — provide critical materials

OEMs / manufacturers — design and produce occluders

Technology providers — develop underlying technologies

System integrators / EPCs — integrate devices into healthcare systems

Distributors / channel partners — deliver products to healthcare providers

Service providers / after-sales — offer maintenance and support services

Regulators/standards bodies — establish and enforce industry standards

Recent Industry Insights

Analyst Overview

Table of Contents